Kenta Mukaihara

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma.

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma.

Journal: Oncotarget

Published: April 23, 2018

PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.

PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.

Journal: Oncotarget

Published: January 30, 2018

IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.

IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.

Journal: Oncotarget

Published: September 04, 2017

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.

Journal: PloS one

Published: April 03, 2017

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors.

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors.

Journal: Oncotarget

Published: March 31, 2017

Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.

Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.

Journal: Oncotarget

Published: May 23, 2016

Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.

Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: April 17, 2016

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.

Journal: PloS one

Published: October 14, 2015

TERT promoter mutations are a rare event in gastrointestinal stromal tumors.

TERT promoter mutations are a rare event in gastrointestinal stromal tumors.

Journal: SpringerPlus

Published: October 07, 2015

TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.

TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.

Journal: Molecular and clinical oncology

Published: July 08, 2015

The role of therapeutic target tyrosine kinases and inhibitors and its current situation in bone and soft tissue tumor

The role of therapeutic target tyrosine kinases and inhibitors and its current situation in bone and soft tissue tumor

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 14, 2015

Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma.

Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma.

Journal: BMC cancer

Published: April 16, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026